lobbying_activities: 1407682
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1407682 | e4955a74-bc65-42e4-bdb3-2e0d5f560d1c | Q2 | GOLDBUG STRATEGIES LLC | 400701094 | GENOMIC HEALTH INC. | 2013 | second_quarter | MED | FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-07-16T09:43:29.757000-04:00 |